INVESTOR NEWS

Oct 23, 2025

Study Confirms the Value of Calprotectin in Early Detection of Neonatal Infections and Sepsis

Belgrade, October 23, 2025 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..

Oct 23, 2025

Gentian Diagnostics: Third quarter 2025 report

Moss, 23 October 2025 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic tests,..

Oct 16, 2025

Invitation to presentation of third quarter results

Gentian Diagnostics ASA will present its third quarter 2025 results on 23 October 2025 at 09.00 CEST.

Jul 03, 2025

Invitation to presentation of second quarter results

Gentian Diagnostics ASA will present its second quarter 2025 results on 10 July 2025 at 09.00 CEST.

Apr 11, 2025

Gentian Diagnostics: Notice of annual general meeting

Gentian Diagnostics ASA’s annual general meeting will be held on Tuesday 6 May 2025 at 11:00 at the company’s..

Mar 21, 2025

Gentian Diagnostics: Annual report 2024

Moss, 21 March 2025 Gentian Diagnostics has today published its annual report for 2024. The annual report and..